Search

Your search keyword '"Gunn, Roger N"' showing total 911 results

Search Constraints

Start Over You searched for: Author "Gunn, Roger N" Remove constraint Author: "Gunn, Roger N"
911 results on '"Gunn, Roger N"'

Search Results

3. PET Parametric Imaging: Past, Present, and Future

4. Brain Serotonin Release Is Reduced in Patients With Depression: A [11C]Cimbi-36 Positron Emission Tomography Study With a d-Amphetamine Challenge

7. Relationship between astrocyte reactivity, using novel 11C-BU99008 PET, and glucose metabolism, grey matter volume and amyloid load in cognitively impaired individuals

10. The relationship between SV2A levels, neural activity, and cognitive function in healthy humans: A [11C]UCB-J PET and fMRI study

11. Estimating Braak stage from [18F]MK6240 PET scans

13. The relationship between synaptic density marker SV2A, glutamate and N-acetyl aspartate levels in healthy volunteers and schizophrenia: a multimodal PET and magnetic resonance spectroscopy brain imaging study

17. Serotonergic pathology and disease burden in the premotor and motor phase of A53T α-synuclein parkinsonism: a cross-sectional study

19. Evaluation of Intraperitoneal [ 18 F]-FDOPA Administration for Micro-PET Imaging in Mice and Assessment of the Effect of Subchronic Ketamine Dosing on Dopamine Synthesis Capacity.

21. Disease-related patterns of in vivo pathology in Corticobasal syndrome

22. Synaptic Terminal Density Early in the Course of Schizophrenia: An In Vivo UCB-J Positron Emission Tomographic Imaging Study of Synaptic Vesicle Glycoprotein 2A

25. Guidelines for the content and format of PET brain data in publications and archives: A consensus paper

26. Synaptic terminal density early in the course of schizophrenia: an in vivo UCB-J positron emission tomographic imaging study of synaptic vesicle glycoprotein 2A (SV2a)

27. A PET-CT study on neuroinflammation in Huntington’s disease patients participating in a randomized trial with laquinimod

34. In Vivo Head‐To‐Head Comparison of [ 18 F]GTP1 and [ 18 F]PI2620 in Alzheimer’s Disease

36. A Generalised Spatio-Temporal Registration Framework for Dynamic PET Data: Application to Neuroreceptor Imaging

37. Spatial-temporal Pharmacokinetic Model Based Registration of 4D Brain PET Data

38. Evaluation of Intraperitoneal [18F]-FDOPA Administration for Micro-PET Imaging in Mice and Assessment of the Effect of Subchronic Ketamine Dosing on Dopamine Synthesis Capacity

39. Neurons derived from individual early Alzheimer’s disease patients reflect their clinical vulnerability

40. Brain Serotonin Release Is Reduced in Patients With Depression: A [11C]Cimbi-36 Positron Emission Tomography Study With a d-Amphetamine Challenge

41. A Visual Interpretation Algorithm for Assessing Brain Tauopathy with 18-F MK-6240 Positron Emission Tomography

42. Astrogliosis in aging and Parkinson’s disease dementia: a new clinical study with 11C-BU99008 PET

43. Widespread cell stress and mitochondrial dysfunction occur in patients with early Alzheimer’s disease

Catalog

Books, media, physical & digital resources